Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 116.00
-1.90 (-1.61%)
Aug 29, 2025, 5:36 PM CET
Ipsen Revenue
Ipsen had revenue of 1.94B EUR in the half year ending June 30, 2025, with 19.35% growth. This brings the company's revenue in the last twelve months to 3.76B, up 11.54% year-over-year. In the year 2024, Ipsen had annual revenue of 3.57B with 8.11% growth.
Revenue (ttm)
3.76B
Revenue Growth
+11.54%
P/S Ratio
2.54
Revenue / Employee
701.72K
Employees
5,358
Market Cap
9.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.57B | 268.10M | 8.11% |
| Dec 31, 2023 | 3.31B | 150.00M | 4.75% |
| Dec 31, 2022 | 3.16B | 407.80M | 14.84% |
| Dec 31, 2021 | 2.75B | 62.40M | 2.32% |
| Dec 31, 2020 | 2.69B | -6.60M | -0.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |
Ipsen News
- 10 days ago - Ipsen S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) - GlobeNewsWire
- 5 weeks ago - Ipsen granted EU nod for Exelixis-partnered cancer drug for neuroendocrine tumors - Seeking Alpha
- 2 months ago - Madrigal, Ipsen, SpringWorks get EU backing for their drugs - Seeking Alpha
- 3 months ago - Ipsen S.A. - Initiation of the share buy-back program - GlobeNewsWire
- 3 months ago - Ipsen S.A. - Annual General Meeting held on 21 May 2025 - GlobeNewsWire
- 4 months ago - Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting - GlobeNewsWire
- 4 months ago - Ipsen S.A. (IPSEY) Q1 2025 Earnings Call Transcript - Seeking Alpha